|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.36 USD | -0.96% |
|
-1.10% | -5.58% |
| Market Cap | 4.38B 3.84B 3.55B 3.27B 6.16B 423B 6.26B 42.47B 16.65B 207B 16.46B 16.1B 713B | P/E 2026 * |
66.6x | P/E 2027 * | 34.8x |
|---|---|---|---|---|---|
| Enterprise Value | 3.42B 3B 2.77B 2.55B 4.81B 330B 4.88B 33.12B 12.98B 161B 12.84B 12.56B 556B | EV / Sales 2026 * |
2.76x | EV / Sales 2027 * | 2.3x |
| Free-Float |
99.68% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: ACADIA Pharmaceuticals Inc.
| 1 day | -1.43% | ||
| 1 week | -1.10% | ||
| Current month | -0.32% | ||
| 1 month | +14.17% | ||
| 3 months | +14.17% | ||
| 6 months | -4.07% | ||
| Current year | -5.58% |
| 1 week | 24.95 |  | 26.23 |
| 1 month | 21.59 | | 27.31 |
| Current year | 19.89 | | 27.81 |
| 1 year | 19.69 | | 28.35 |
| 3 years | 13.4 | | 32.59 |
| 5 years | 12.24 | | 33.99 |
| 10 years | 12.24 | | 58.72 |
| Manager | Title | Age | Since |
|---|---|---|---|
Catherine Adams
CEO | Chief Executive Officer | 55 | 19/09/2024 |
Mark Schneyer
DFI | Director of Finance/CFO | 52 | 09/09/2021 |
Scott Cenci
CTO | Chief Tech/Sci/R&D Officer | - | 03/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Laura Brege
BRD | Director/Board Member | 68 | 30/04/2008 |
Stephen Biggar
CHM | Chairman | 55 | 09/06/2016 |
Edmund Harrigan
BRD | Director/Board Member | 73 | 24/11/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 26/06/26 | Sell | Controller/Auditor | -11,421 | 0.0067% | ||
| 29/05/26 | Fiscal year | Director | 41,529 | 0.0243% | ||
| 29/05/26 | Fiscal year | Director | 29,335 | 0.0171% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.96% | -1.10% | +13.20% | -19.32% | 4.38B | |
| -0.49% | -4.01% | +0.61% | +2.28% | 49.18B | |
| -1.61% | -0.13% | +378.16% | +584.97% | 39.58B | |
| -0.47% | +2.77% | +7.01% | +61.95% | 34.69B | |
| -0.50% | -0.97% | +29.30% | -9.20% | 34.42B | |
| -1.82% | -1.48% | +0.52% | +32.02% | 27.11B | |
| -2.43% | -4.12% | - | - | 16.21B | |
| -1.02% | +0.74% | +72.92% | +116.33% | 15.36B | |
| +1.17% | +2.30% | +15.46% | +18.26% | 14.05B | |
| -2.25% | +0.28% | +19.29% | -32.68% | 13.02B | |
| Average | -0.89% | -0.39% | +59.61% | +83.85% | 24.8B | |
| Weighted average by Cap. | -0.76% | -0.41% | +77.26% | +118.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.24B 1.09B 1.01B 925M 1.74B 120B 1.77B 12.02B 4.71B 58.55B 4.66B 4.56B 202B | 1.4B 1.22B 1.13B 1.04B 1.96B 135B 1.99B 13.52B 5.3B 65.83B 5.24B 5.12B 227B |
| Net income | 65.75M 57.63M 53.27M 49M 92.44M 6.34B 93.93M 637M 250M 3.1B 247M 242M 10.69B | 134M 117M 108M 99.66M 188M 12.9B 191M 1.3B 508M 6.31B 502M 491M 21.74B |
| Net Debt | -965M -845M -781M -719M -1.36B -93.01B -1.38B -9.34B -3.66B -45.51B -3.62B -3.54B -157B | -1.18B -1.03B -954M -877M -1.65B -114B -1.68B -11.4B -4.47B -55.54B -4.42B -4.32B -191B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/07/26 | US$25.27 | -1.29% | 932,830 |
| 17/07/26 | US$25.60 | -0.12% | 1,207,375 |
| 16/07/26 | US$25.63 | -1.12% | 2,189,326 |
| 15/07/26 | US$25.92 | +1.69% | 1,274,099 |
| 14/07/26 | US$25.49 | -0.04% | 1,221,006 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ACAD Stock
Select your edition
All financial news and data tailored to specific country editions
